Skip to main content

Table 2 Characteristics of the eyes within the retinal conditions group

From: Identification of epiretinal proliferation in various retinal diseases and vitreoretinal interface disorders

  AMD Diabetic retinopathy Refractory chronic CME Vein occlusion High myopia All eyes
N, eyes 14 (30.4%) 10 (21.7%) 10 (21.7%) 8 (17.4%) 4 (8.7%) 46 (100.0%)
Clinical data
 Visual acuity, LogMAR 0.31 ± 0.22 0.47 ± 0.66 0.74 ± 0.69 0.30 ± 0.13 0.27 ± 0.20 0.43 ± 0.48
 Phakic lens status 0 (0%) 2 (20.0%) 1 (10.0%) 0 (0%) 0 (0%) 3 (6.5%)
 Glaucoma 3 (21.4%) 8 (80.0%) 4 (40.0%) 5 (62.5%) 1 (25.0%) 21 (45.7%)
 History of macular edema 8 (57.1%) 10 (100.0%) 10 (100.0%) 8 (100.0%) 0 (0%) 36 (78.3%)
Intravitreal injections
 Anti-VEGF 7 (87.5%) 9 (90.0%) 5 (50.0%) 6 (75.0%) 0 (0%) 27 (58.7%)
 Steroids 0 (0%) 2 (20.0%) 5 (50.0%) 2 (25.0%) 0 (0%) 9 (16.1%)
Laser treatment
 PRP 0 (0%) 9 (90.0%) 0 (0%) 6 (75.0%) 0 (0%) 15 (32.6%)
 FML 0 (0%) 3 (33.3%) 0 (0%) 0 (0%) 0 (0%) 3 (6.5%)
Retinal tear 0 (0%) 1 (10.0%) 0 (0%) 0 (0%) 2 (50.0%) 3 (6.5%)
Retinal detachment 0 (0%) 0 (0.0%) 5 (50.0%) 0 (0%) 1 (25.0%) 6 (13.0%)
SD-OCT features
 Macular PVD 10/12 (83.3%) 2/5 (40.0%) 3/3 (100.0%) 6/7 (85.7%) 3/4 (75.0%) 24/31 (77.4%)
 ERM 7 (50.0%) 6 (60.0% 8 (80.0%) 5 (62.5%) 1 (25.0%) 27 (58.7%)
 Macular edema 3 (21.4%) 4 (40.0%) 8 (80.0%) 2 (25.0%) 0 (0%) 17 (37.0%)
 ELM disruption 10 (71.4%) 6 (60.0%) 6 (60.0%) 4 (50.0%) 3 (75.0%) 29 (63.0%)
 EZ disruption 10 (71.4%) 9 (90.0%) 8 (80.0%) 5 (62.5%) 3 (75.0%) 35 (76.1%)
 N, ETDRS quadrants 1.4 ± 0.6 4.0 ± 2.6 3.3 ± 2.5 3.6 ± 1.7 1.3 ± 0.5 2.7 ± 2.1
  1. N number, VEGF vascular endothelial growth factor, PRP pan-retinal photocoagulation, FML focal macular laser, SD-OCT spectral domain optical coherence tomography, PVD posterior vitreous detachment, ERM epiretinal membrane, ELM external limiting membrane, EZ ellipsoidal zone, ETDRS early treatment diabetic retinopathy study
  2. Vitrectomized eyes are not included